These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38680981)

  • 1. Innate Immune Dysfunction and Neuroinflammation in Autism Spectrum Disorder (ASD).
    Hughes HK; Moreno RJ; Ashwood P
    Focus (Am Psychiatr Publ); 2024 Apr; 22(2):229-241. PubMed ID: 38680981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD).
    Hughes HK; R J Moreno ; Ashwood P
    Brain Behav Immun; 2023 Feb; 108():245-254. PubMed ID: 36494048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia: Synaptic modulator in autism spectrum disorder.
    Hu C; Li H; Li J; Luo X; Hao Y
    Front Psychiatry; 2022; 13():958661. PubMed ID: 36465285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Non-inflammatory Role for Microglia in Autism Spectrum Disorders.
    Edmonson CA; Ziats MN; Rennert OM
    Front Neurol; 2016; 7():9. PubMed ID: 26869989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Monocyte Production of IL-6 after Toll-like Receptor Activation in Children with Autism Spectrum Disorder (ASD) Is Associated with Repetitive and Restricted Behaviors.
    Hughes HK; Onore CE; Careaga M; Rogers SJ; Ashwood P
    Brain Sci; 2022 Feb; 12(2):. PubMed ID: 35203983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of neuroinflammation in Autism Spectrum Disorder.
    Matta SM; Hill-Yardin EL; Crack PJ
    Brain Behav Immun; 2019 Jul; 79():75-90. PubMed ID: 31029798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation.
    Melamed IR; Heffron M; Testori A; Lipe K
    Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders.
    Hughes HK; Mills Ko E; Rose D; Ashwood P
    Front Cell Neurosci; 2018; 12():405. PubMed ID: 30483058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal Cell Adhesion Molecules May Mediate Neuroinflammation in Autism Spectrum Disorder.
    Eve M; Gandawijaya J; Yang L; Oguro-Ando A
    Front Psychiatry; 2022; 13():842755. PubMed ID: 35492721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Autism Spectrum Disorder: A Neuroinflammatory Mediated Mechanism of Pathogenesis?
    Zarimeidani F; Rahmati R; Mostafavi M; Darvishi M; Khodadadi S; Mohammadi M; Shamlou F; Bakhtiyari S; Alipourfard I
    Inflammation; 2024 Aug; ():. PubMed ID: 39093342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders.
    Bilbo SD; Block CL; Bolton JL; Hanamsagar R; Tran PK
    Exp Neurol; 2018 Jan; 299(Pt A):241-251. PubMed ID: 28698032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune dysregulation in autism spectrum disorder.
    Hsiao EY
    Int Rev Neurobiol; 2013; 113():269-302. PubMed ID: 24290389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PM
    Ahadullah ; Yau SY; Lu HX; Lee TMC; Guo H; Chan CCH
    Neurosci Biobehav Rev; 2021 Sep; 128():534-548. PubMed ID: 34216652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Auditory Nerve Impairment in a Mouse Model of Syndromic Autism.
    McChesney N; Barth JL; Rumschlag JA; Tan J; Harrington AJ; Noble KV; McClaskey CM; Elvis P; Vaena SG; Romeo MJ; Harris KC; Cowan CW; Lang H
    J Neurosci; 2022 Oct; 42(42):8002-8018. PubMed ID: 36180228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-emerging concepts of immune dysregulation in autism spectrum disorders.
    Erbescu A; Papuc SM; Budisteanu M; Arghir A; Neagu M
    Front Psychiatry; 2022; 13():1006612. PubMed ID: 36339838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():615-646. PubMed ID: 32006377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence supporting an altered immune response in ASD.
    Mead J; Ashwood P
    Immunol Lett; 2015 Jan; 163(1):49-55. PubMed ID: 25448709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
    Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
    World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors.
    Breece E; Paciotti B; Nordahl CW; Ozonoff S; Van de Water JA; Rogers SJ; Amaral D; Ashwood P
    Brain Behav Immun; 2013 Jul; 31():69-75. PubMed ID: 23063420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Therapies for Autism Spectrum Disorder Based on New Pathophysiology: A Review.
    Nabetani M; Mukai T; Taguchi A
    Cell Transplant; 2023; 32():9636897231163217. PubMed ID: 36999673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.